Subsequent Bevacizumab Treatment in Patients With HHT. Follow up BABH

Clinical trial NCT06039124 · COMPLETED

Trial details

NCT number: NCT06039124
Sponsor: Hospices Civils de Lyon
Status: COMPLETED
Study type: OBSERVATIONAL

Hemorrhagic Hereditary Telangiectasia HHT

Start date: 2021-09-01
Primary completion: 2022-01-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.